XClose

UCL Institute for Innovation and Public Purpose

Home
Menu

Philip Mirowski talk: The infirmity of open science in pharmaceutical research

6:30 pm to 8:00 pm, 04 June 2019

Philip Mirowski: The infirmity of open science in pharmaceutical research

This event is free.

Event Information

Open to

All

Availability

Yes

Cost

Free

Organiser

IIPP Comms Team

Location

JZ Young Lecture Theatre
G29, Anatomy Building
Gower Street
London
WC1E 6XA
United Kingdom

Rather than the panacea for the ills of science in the 21st century, open science is a Trojan Horse for reinforcing the neoliberal commercialisation of science; thus argues prominent historian and philosopher Philip Mirowski. In this event, he presents further evidence from the pharmaceuticals sector to support this thesis and demonstrate how the program is failing.

A panel discussion chaired by UCL Institute for Innovation and Public Purpose (IIPP) Director Mariana Mazzucato will follow, featuring Jack Stilgoe (UCL Department of Science and Technology Studies) and Matthew Todd (Open Source Pharma and UCL School of Pharmacy). More speakers to be announced.

Refreshments will be provided.

This event will also be live-streamed to the UCL Institute for Innovation and Public Purpose (IIPP) Facebook page.

About the Speakers

Philip Mirowski

Philip Mirowski is Carl Koch Professor of Economics and the History and Philosophy of Science at the University of Notre Dame. He is the author of, among others, The Knowledge we have Lost in Information (2017), More Heat than Light (1989), Machine Dreams (2001), ScienceMart (2011), andNever Let a Serious Crisis Go to Waste (2013). He is a recipient of the Ludwig Fleck Prize from the Society for Social Studies of Science, and was named Distinguished Scholar by the History of Economics Society. He has been visiting professor at Yale, University of Massachusetts, Amsterdam, Oxford All Souls, Montevideo, and Paris-Sorbonne. A conference devoted to his work was held by the boundary 2 collective in 2017. His recent researchon the problems of open science has appeared in Social Studies of Science. Outside of the economics profession, he is perhaps best known for his work on the history and political philosophy of neoliberalism, and his methodological watchword that intellectual history is the story of thought collectives, not heroic individuals.

Jack Stilgoe

Senior lecturer at UCL Department of Science and Technology Studies

Dr Jack Stilgoe is a Senior Lecturer in Social Studies of Science at University College London. He has spent his professional life in the overlap between science policy research and science policy practice, first at UCL’s department of Science and Technology Studies, then at the think tank Demos, then the Royal Society and then the University of Exeter.

More about Jack Stilgoe

Matthew Todd

Professor in drug discovery at Open Source Pharma and UCL School of Pharmacy

Mat Todd was born in Manchester, England. He obtained his PhD in organic chemistry from Cambridge University in 1999, was a Wellcome Trust postdoc at The University of California, Berkeley, a college fellow back at Cambridge University, a lecturer at Queen Mary, University of London and between 2005 and 2018 was at the School of Chemistry, The University of Sydney. He is now Chair of Drug Discovery at University College London. 

More about Matthew Todd

Mariana Mazzucato

Director at UCL Institute for Innovation and Public Purpose (IIPP)

Mariana Mazzucato (PhD) is Professor in the Economics of Innovation and Public Value at UCL, and is Founder and Director of the UCL Institute for Innovation & Public Purpose (IIPP). She is winner of the 2014 New Statesman SPERI Prize in Political Economy, the 2015 Hans-Matthöfer-Preis, and the 2018 Leontief Prize for Advancing the Frontiers of Economic Thought. She was named as one of the '3 most important thinkers about innovation' by the New Republic.

More about Mariana Mazzucato